290 related articles for article (PubMed ID: 28942620)
1. Current status and strategies for viral hepatitis control in Korea.
Sinn DH; Cho EJ; Kim JH; Kim DY; Kim YJ; Choi MS
Clin Mol Hepatol; 2017 Sep; 23(3):189-195. PubMed ID: 28942620
[TBL] [Abstract][Full Text] [Related]
2. Current status and strategies for hepatitis B control in Korea.
Cho EJ; Kim SE; Suk KT; An J; Jeong SW; Chung WJ; Kim YJ
Clin Mol Hepatol; 2017 Sep; 23(3):205-211. PubMed ID: 28942624
[TBL] [Abstract][Full Text] [Related]
3. Current status of and strategies for hepatitis C control in South Korea.
Kim BK; Jang ES; Kim JH; Park SY; Ahn SV; Kim HJ; Kim DY
Clin Mol Hepatol; 2017 Sep; 23(3):212-218. PubMed ID: 28942625
[TBL] [Abstract][Full Text] [Related]
4. Current status and strategies for the control of viral hepatitis A in Korea.
Yoon EL; Sinn DH; Lee HW; Kim JH
Clin Mol Hepatol; 2017 Sep; 23(3):196-204. PubMed ID: 28942621
[TBL] [Abstract][Full Text] [Related]
5. [The ABC of viral hepatitis].
Van Bambeke F
J Pharm Belg; 2008 Mar; 63(1):15-20. PubMed ID: 18479077
[TBL] [Abstract][Full Text] [Related]
6. Comparing the Clinical Features and Outcomes of Acute Hepatitis E Viral Infections with Those of Acute Hepatitis A, B, and C Infections in Korea.
Oh HW; Cha RR; Lee SS; Lee CM; Kim WS; Jo YW; Kim JJ; Lee JM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ
Intervirology; 2017; 60(3):109-117. PubMed ID: 29145204
[TBL] [Abstract][Full Text] [Related]
7. Viral hepatitis. From prevention to antivirals.
Jonas MM
Clin Liver Dis; 2000 Nov; 4(4):849-77. PubMed ID: 11232361
[TBL] [Abstract][Full Text] [Related]
8. [Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E].
Bartenschlager R; Cornberg M; Pietschmann T
Internist (Berl); 2017 Jul; 58(7):666-674. PubMed ID: 28631044
[TBL] [Abstract][Full Text] [Related]
9. Viral hepatitis in solid organ transplantation other than liver.
Vallet-Pichard A; Fontaine H; Mallet V; Pol S
J Hepatol; 2011 Aug; 55(2):474-82. PubMed ID: 21241754
[TBL] [Abstract][Full Text] [Related]
10. Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination.
Higuera-de la Tijera F; Servín-Caamaño A; Servín-Abad L
World J Gastroenterol; 2021 Jul; 27(26):4004-4017. PubMed ID: 34326610
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and hepatitis C in 2009.
Marcellin P
Liver Int; 2009 Jan; 29 Suppl 1():1-8. PubMed ID: 19207959
[TBL] [Abstract][Full Text] [Related]
12. HEP DART 2003: Frontiers in drug development for viral hepatitis.
Raney AK; Hamatake RK; Hong Z
Expert Opin Investig Drugs; 2004 Mar; 13(3):289-93. PubMed ID: 15013947
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis elimination by 2030: Progress and challenges.
Waheed Y; Siddiq M; Jamil Z; Najmi MH
World J Gastroenterol; 2018 Nov; 24(44):4959-4961. PubMed ID: 30510370
[TBL] [Abstract][Full Text] [Related]
14. Progress on global hepatitis elimination targets.
Waheed Y
World J Gastroenterol; 2021 Dec; 27(47):8199-8200. PubMed ID: 35068864
[TBL] [Abstract][Full Text] [Related]
15. Current status of hepatitis C virus infection in Korea.
Suh DJ; Jeong SH
Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
[TBL] [Abstract][Full Text] [Related]
16. The impact of human immunodeficiency virus on viral hepatitis.
Mallet V; Vallet-Pichard A; Pol S
Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
[TBL] [Abstract][Full Text] [Related]
17. Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings.
Easterbrook P; Sands A; Harmanci H
Semin Liver Dis; 2012 May; 32(2):147-57. PubMed ID: 22760654
[TBL] [Abstract][Full Text] [Related]
18. Management of viral hepatitis in liver transplant recipients.
Jeong SW; Choi Y; Kim JW
Clin Mol Hepatol; 2014 Dec; 20(4):338-44. PubMed ID: 25548738
[TBL] [Abstract][Full Text] [Related]
19. Novel approaches to new therapies for hepatitis B virus infection.
Loomba R; Liang TJ
Antivir Ther; 2006; 11(1):1-15. PubMed ID: 16518955
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Advances in Viral Hepatitis A-E.
Nagra N; Kozarek RA; Burman BE
Adv Ther; 2022 Apr; 39(4):1524-1552. PubMed ID: 35220557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
